Samuel Reich
Net worth: 78 840 $ as of 2026-05-30
Net worth: 78 840 $ as of 2026-05-30
Samuel J.
Reich was the founder of Acuity Pharmaceuticals, Inc., founded in 2002, where the title held was Vice President-Research & Development from 2002 to 2007.
Mr. Reich is the founder of Biscayne Pharmaceuticals, Inc., founded in 2011, holding the title of President & Director.
Mr. Reich is the founder of Biscayne Neurotherapeutics, Inc., founded in 2011, with the title of Executive Chairman & President from 2011 to 2018.
Current jobs include Chief Executive Officer & Director at SAB Biotherapeutics, Inc. starting in 2021, and Executive Chairman at SAB Sciences, Inc. Former jobs include Director, Chief Executive & Financial Officer at Big Cypress Acquisition Corp.
from 2020 to 2021, Executive Vice President at eXegenics, Inc. in 2007, and Executive Vice President-Ophthalmologics at OPKO Health, Inc. from 2007 to 2008.
Education includes undergraduate studies at Clark University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-01 | 21,900 ( 0.05% ) | 78 840 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Chief Executive Officer | 2024-02-01 |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Chairman | - |
| Companies | Position | End |
|---|---|---|
| BIG CYPR | Chief Executive Officer | 2021-10-21 |
Biscayne Neurotherapeutics, Inc.
Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders | Founder | 2018-09-30 |
Biscayne Pharmaceuticals, Inc.
Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Founder | 2018-09-30 |
| OPKO HEALTH, INC. | Corporate Officer/Principal | 2008-10-31 |
eXegenics, Inc.
eXegenics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2007-06-12 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
eXegenics, Inc.
eXegenics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Acuity Pharmaceuticals, Inc.
Acuity Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Developed pharmaceutical products | Commercial Services |
Biscayne Pharmaceuticals, Inc.
Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Health Technology |
Clark University
Clark University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OPKO Health, Inc.
OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
Biscayne Neurotherapeutics, Inc.
Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders | Health Technology |
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical development company | Health Technology |
Big Cypress Acquisition Corp.
Big Cypress Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions